However, mutations in β-catenin/CTNNB1, which are not uncommon in various cancer entities and in some mesenchymal tumors [96,97,98], are consistently absent in ILC [43,99]. This evidence concerns the gene CTNNB1 and mesenchymal cell neoplasm.